Latest biopharmaceutical Stories
- 24 UCB-sponsored presentations including new data on VIMPAT® (lacosamide) BRUSSELS, Dec.
FREMONT, Calif., Dec. 1, 2014 /PRNewswire/ -- Ardelyx, Inc.
DALLAS and NEW YORK, Nov. 24, 2014 /PRNewswire/ -- PlasmaTech Biopharmaceuticals, Inc. announced today that FINRA has approved a change of Company's stock ticker symbol.
BOULDER, Colo., Nov. 19, 2014 /PRNewswire/ -- N30 Pharmaceuticals, Inc.
-- Data Published Online in the Journal of the American Society of Nephrology -- FREMONT, Calif., Nov. 17, 2014 /PRNewswire/ -- Ardelyx, Inc.
- Treatment with RG-012 Protects Kidney Function and Demonstrates Additive Therapeutic Effect with Emerging Standard of Care in Preclinical Model of Alport Syndrome - LA JOLLA, Calif.,
U.S. Patent No. 8,871,493 "Transformation system in the field of filamentous fungal hosts" JUPITER, Fla., Nov. 12, 2014 /PRNewswire/ -- Dyadic International, Inc.
- Forsooth! indeed! originally a parenthetical phrase used in repeating the words of another with more or less contempt or disdain.